A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy

Completed · Phase 2

Conditions studied: Narcolepsy

In brief

The purpose of this study is to evaluate the safety and effectiveness of JNJ-17216498 compared to modafinil and placebo in patients with narcolepsy, with and without cataplexy.

Key facts

Study ID
NCT00424931
Run by
Alza Corporation, DE, USA
People needed
16
Starts
2007-01-01
Expected to finish
2007-12-01
Last updated by the study team
2014-05-23

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.